Why Low-Fat Products Are Not As Popular As Natural Fats.
The creaminess of fat-rich foods such as ice cream and salad dressing petition to many, but remodelled affirmation indicates that some people can actually "taste" the fat lurking in luxurious foods and that those who can't may end up eating more of those foods. In a series of studies presented at the 2011 Institute of Food Technologists annual union this week, scientists said research increasingly supports the whim that fat and fatty acids can be tasted, though they're primarily detected through smell and texture.
Those who can't come up against the fat have a genetic variant in the way they process food, researchers said, in any way leading them to crave fat subconsciously. "Those more sensitive to the fat content were better at controlling their weight," said Kathleen L Keller, a dig into associate at New York Obesity Research Center at St Luke's Roosevelt Hospital.
And "We mark these people were protected from avoirdupois because of their ability to detect small changes in fat content". Keller and her colleagues wilful 317 healthy black adults, identifying a common variant in the CD36 gene that was linked to self-reported preferences for added fats such as butters, oils and spreads.
The same separate was also found to be linked with a selection for fat in fluid dairy samples in a smaller group of children. Keller said it was consequential to confine the study sample to one ethnic group to limit possible gene variations.
Her tandem asked participants about their normal diets and how oily or creamy they perceived salad dressings with obese content ranging from 5 percent to 55 percent. About 21 percent of the party had what the researchers called the "at-risk" genotype, reporting a fondness for fatty foods and perceiving the dressings to be creamier than other groups, she said.
Tuesday 20 January 2015
Saturday 10 January 2015
Acupuncture Can Treat Some Types Of Amblyopia
Acupuncture Can Treat Some Types Of Amblyopia.
Acupuncture may be an noticeable scheme to treat older children struggling with a certain form of lazy eye, late research from China suggests, although experts say more studies are needed. Lazy eye (amblyopia) is essentially a status of miscommunication between the brain and the eyes, resulting in the favoring of one eye over the other, according to the National Eye Institute. The turn over authors noted that anywhere from less than 1 percent to 5 percent of mobile vulgus worldwide are affected with the condition. Of those, between one third and one half have a personification of lazy eye known as anisometropia, which is caused by a difference in the degree of nearsightedness or farsightedness between the two eyes.
Standard curing for children involves eyeglasses or contact lens designed to correct heart issues. However, while this approach is often successful in younger children (between the ages of 3 and 7), it is triumphant among only about a third of older children (between the ages of 7 and 12). For the latter group, doctors will often chore a patch over the "good" eye temporarily in addition to eyeglasses, and healing success is typically achieved in two-thirds of cases.
Children, however, often have trouble adhering to area therapy, the treatment can bring emotional issues for some and a reverse form of lazy eye can also accompany root, the researchers said. Study author Dr Dennis SC Lam, from the segment of ophthalmology and visual sciences and Institute of Chinese Medicine at the Joint Shantou International Eye Center of Shantou University and Chinese University of Hong Kong, and his colleagues clock in their observations in the December dissemination of the Archives of Ophthalmology.
In the search for a better option than patch therapy, Lam and his associates set out to research the potential benefits of acupuncture, noting that it has been used to treat dry eye and myopia. Between 2007 and 2009, Lam and his colleagues recruited 88 children between the ages of 7 and 12 who had been diagnosed with anisometropia.
About half the children were treated five times a week with acupuncture, targeting five unambiguous acupuncture needle insertion points (located at the prune of the leader and the eyebrow region, as well as the legs and hands). The other half were given two hours a age of plat therapy, combined with a minimum of one hour per day of near-vision exercises such as reading.
After about four months of treatment, the examine team found that overall visual acuity improved markedly more among the acupuncture crowd relative to the patch group. In fact, they noted that while lazy eye was successfully treated in nearly 42 percent of the acupuncture patients, that form dropped to less than 17 percent in the midst the patch patients.
Acupuncture may be an noticeable scheme to treat older children struggling with a certain form of lazy eye, late research from China suggests, although experts say more studies are needed. Lazy eye (amblyopia) is essentially a status of miscommunication between the brain and the eyes, resulting in the favoring of one eye over the other, according to the National Eye Institute. The turn over authors noted that anywhere from less than 1 percent to 5 percent of mobile vulgus worldwide are affected with the condition. Of those, between one third and one half have a personification of lazy eye known as anisometropia, which is caused by a difference in the degree of nearsightedness or farsightedness between the two eyes.
Standard curing for children involves eyeglasses or contact lens designed to correct heart issues. However, while this approach is often successful in younger children (between the ages of 3 and 7), it is triumphant among only about a third of older children (between the ages of 7 and 12). For the latter group, doctors will often chore a patch over the "good" eye temporarily in addition to eyeglasses, and healing success is typically achieved in two-thirds of cases.
Children, however, often have trouble adhering to area therapy, the treatment can bring emotional issues for some and a reverse form of lazy eye can also accompany root, the researchers said. Study author Dr Dennis SC Lam, from the segment of ophthalmology and visual sciences and Institute of Chinese Medicine at the Joint Shantou International Eye Center of Shantou University and Chinese University of Hong Kong, and his colleagues clock in their observations in the December dissemination of the Archives of Ophthalmology.
In the search for a better option than patch therapy, Lam and his associates set out to research the potential benefits of acupuncture, noting that it has been used to treat dry eye and myopia. Between 2007 and 2009, Lam and his colleagues recruited 88 children between the ages of 7 and 12 who had been diagnosed with anisometropia.
About half the children were treated five times a week with acupuncture, targeting five unambiguous acupuncture needle insertion points (located at the prune of the leader and the eyebrow region, as well as the legs and hands). The other half were given two hours a age of plat therapy, combined with a minimum of one hour per day of near-vision exercises such as reading.
After about four months of treatment, the examine team found that overall visual acuity improved markedly more among the acupuncture crowd relative to the patch group. In fact, they noted that while lazy eye was successfully treated in nearly 42 percent of the acupuncture patients, that form dropped to less than 17 percent in the midst the patch patients.
Saturday 3 January 2015
Amphotericin B And Flucytosine For Antifungal Therapy
Amphotericin B And Flucytosine For Antifungal Therapy.
A medicine regimen containing two vigorous antifungal medicines - amphotericin B and flucytosine - reduced the jeopardy of dying from cryptococcal meningitis by 40 percent compared to healing with amphotericin B alone, according to new research in April 2013. The study also found that those who survived the malady were less likely to be disabled if they received treatment that included flucytosine. "Combination antifungal treatment with amphotericin and flucytosine for HIV-associated cryptococcal meningitis significantly reduces the risk of dying from this disease," said the study's starring role author, Dr Jeremy Day, head of the CNS-HIV Infections Group for the Wellcome Trust Major Overseas Program in Vietnam. "This set could save 250000 deaths across Africa and Asia each year.
The indicator to achieving this will be improving access to the antifungal spokesman flucytosine," said Day, also a research lecturer at the University of Oxford. Flucytosine is more than 50 years unused and off patent, according to Day. The drug has few manufacturers, and it isn't licensed for use in many of the countries where the saddle with from this disease is highest.
Where it is available, the limited supply often drives the cost higher, Day noted. "We aspire the results of this study will help drive increased and affordable access to both amphotericin and flucytosine. Infectious complaint specialist Dr Bruce Hirsch, an attending medical doctor at North Shore University Hospital in Manhasset, NY, said that in the United States, "the use of these medicines, amphotericin and flucytosine, is the usual defined of care for this dangerous infection, and is followed by long-term treatment with fluconazole another antifungal".
But, Hirsch esteemed that this infection is unusual to see in the United States. That's decidedly not the case in the rest of the world. There are about 1 million cases of cryptococcal meningitis worldwide each year, and 625000 deaths associated with those infections, according to library background information. Meningitis is an infection of the meninges, the heedful membranes that cover the brain and the spinal cord.
A medicine regimen containing two vigorous antifungal medicines - amphotericin B and flucytosine - reduced the jeopardy of dying from cryptococcal meningitis by 40 percent compared to healing with amphotericin B alone, according to new research in April 2013. The study also found that those who survived the malady were less likely to be disabled if they received treatment that included flucytosine. "Combination antifungal treatment with amphotericin and flucytosine for HIV-associated cryptococcal meningitis significantly reduces the risk of dying from this disease," said the study's starring role author, Dr Jeremy Day, head of the CNS-HIV Infections Group for the Wellcome Trust Major Overseas Program in Vietnam. "This set could save 250000 deaths across Africa and Asia each year.
The indicator to achieving this will be improving access to the antifungal spokesman flucytosine," said Day, also a research lecturer at the University of Oxford. Flucytosine is more than 50 years unused and off patent, according to Day. The drug has few manufacturers, and it isn't licensed for use in many of the countries where the saddle with from this disease is highest.
Where it is available, the limited supply often drives the cost higher, Day noted. "We aspire the results of this study will help drive increased and affordable access to both amphotericin and flucytosine. Infectious complaint specialist Dr Bruce Hirsch, an attending medical doctor at North Shore University Hospital in Manhasset, NY, said that in the United States, "the use of these medicines, amphotericin and flucytosine, is the usual defined of care for this dangerous infection, and is followed by long-term treatment with fluconazole another antifungal".
But, Hirsch esteemed that this infection is unusual to see in the United States. That's decidedly not the case in the rest of the world. There are about 1 million cases of cryptococcal meningitis worldwide each year, and 625000 deaths associated with those infections, according to library background information. Meningitis is an infection of the meninges, the heedful membranes that cover the brain and the spinal cord.
Wednesday 24 December 2014
A New Approach To The Regularity Of Mammography
A New Approach To The Regularity Of Mammography.
A unique arrive challenges the 2009 recommendation from the US Preventive Services Task Force that women between 40 and 49 who are not at violent risk of breast cancer can probably wait to get a mammogram until 50, and even then only shortage the exam every two years. A well-known Harvard Medical School radiologist, penmanship in the July issue of Radiology, says telling women to wait until 50 is precisely out wrong. The task force recommendations, he says, are based on faulty study and should be revised or withdrawn.
So "We know from the scientific studies that screening saves a lot of lives, and it saves lives amongst women in their 40s," said Dr Daniel B Kopans, a professor of radiology at Harvard Medical School and chief radiologist in the breast imaging division at Massachusetts General Hospital in Boston. The US Preventive Services Task Force (USPSTF) said its recommendation, which sparked a firestorm of controversy, was based in field and would hold many women each year from expendable worry and treatment.
But the guidelines left most women confused. The American Cancer Society continued to exhort annual mammograms for women in their 40s, and young breast cancer survivors shared resilient stories about how screening saved their lives. One main mess with the guidelines is that the USPSTF relied on incorrect methods of analyzing data from breast cancer studies, Kopans said.
The danger of breast cancer starts rising gradually during the 40s, 50s and gets higher still during the 60s, he said. But the statistics used by the USPSTF lumped women between 40 and 49 into one group, and women between 50 and 59 in another group, and predetermined those in the younger catalogue were much less likely to develop breast cancer than those in the older group.
That may be true, he said, except that assigning mature 50 as the "right" age for mammography is arbitrary, Kopans said. "A helpmate who is 49 is similar biologically to a woman who is 51," Kopans said. "Breast cancer doesn't supervise your age. There is nothing that changes abruptly at age 50".
Other problems with the USPSTF guidelines, Kopans said, take in the following. The guidelines cite research that shows mammograms are authoritative for a 15 percent reduction in mortality. That's an underestimate. Other studies show screening women in their 40s can bust deaths by as much as 44 percent. Sparing women from unnecessary be anxious over false positives is a poor reason for not screening, since dying of breast cancer is a far worse fate. "They made the self-centred decision that women in their 40s couldn't tolerate the anxiety of being called back because of a in dispute screening study, even though when you ask women who've been through it, most are pleased there was nothing wrong, and studies show they will come back for their next screening even more religiously," Kopans said. "The effort force took the decision away from women. It's incredibly paternalistic". The assignment force recommendation to screen only high-risk women in their 40s will failure the 75 percent of breast cancers that occur among women who would not be considered dear risk, that is, they don't have a strong family history of the disease and they don't have the BRCA1 or BRCA2 genes known to build up cancer risk.
A unique arrive challenges the 2009 recommendation from the US Preventive Services Task Force that women between 40 and 49 who are not at violent risk of breast cancer can probably wait to get a mammogram until 50, and even then only shortage the exam every two years. A well-known Harvard Medical School radiologist, penmanship in the July issue of Radiology, says telling women to wait until 50 is precisely out wrong. The task force recommendations, he says, are based on faulty study and should be revised or withdrawn.
So "We know from the scientific studies that screening saves a lot of lives, and it saves lives amongst women in their 40s," said Dr Daniel B Kopans, a professor of radiology at Harvard Medical School and chief radiologist in the breast imaging division at Massachusetts General Hospital in Boston. The US Preventive Services Task Force (USPSTF) said its recommendation, which sparked a firestorm of controversy, was based in field and would hold many women each year from expendable worry and treatment.
But the guidelines left most women confused. The American Cancer Society continued to exhort annual mammograms for women in their 40s, and young breast cancer survivors shared resilient stories about how screening saved their lives. One main mess with the guidelines is that the USPSTF relied on incorrect methods of analyzing data from breast cancer studies, Kopans said.
The danger of breast cancer starts rising gradually during the 40s, 50s and gets higher still during the 60s, he said. But the statistics used by the USPSTF lumped women between 40 and 49 into one group, and women between 50 and 59 in another group, and predetermined those in the younger catalogue were much less likely to develop breast cancer than those in the older group.
That may be true, he said, except that assigning mature 50 as the "right" age for mammography is arbitrary, Kopans said. "A helpmate who is 49 is similar biologically to a woman who is 51," Kopans said. "Breast cancer doesn't supervise your age. There is nothing that changes abruptly at age 50".
Other problems with the USPSTF guidelines, Kopans said, take in the following. The guidelines cite research that shows mammograms are authoritative for a 15 percent reduction in mortality. That's an underestimate. Other studies show screening women in their 40s can bust deaths by as much as 44 percent. Sparing women from unnecessary be anxious over false positives is a poor reason for not screening, since dying of breast cancer is a far worse fate. "They made the self-centred decision that women in their 40s couldn't tolerate the anxiety of being called back because of a in dispute screening study, even though when you ask women who've been through it, most are pleased there was nothing wrong, and studies show they will come back for their next screening even more religiously," Kopans said. "The effort force took the decision away from women. It's incredibly paternalistic". The assignment force recommendation to screen only high-risk women in their 40s will failure the 75 percent of breast cancers that occur among women who would not be considered dear risk, that is, they don't have a strong family history of the disease and they don't have the BRCA1 or BRCA2 genes known to build up cancer risk.
Saturday 6 December 2014
Family Doctors Will Keep Electronic Medical Records
Family Doctors Will Keep Electronic Medical Records.
More than two-thirds of kids doctors now use electronic fitness records, and the percentage doing so doubled between 2005 and 2011, a unusual study finds. If the trend continues, 80 percent of family doctors - the largest bunch of primary care physicians - will be using electronic records by 2013, the researchers predicted. The findings produce "some encouragement that we have passed a critical threshold," said scan author Dr Andrew Bazemore, director of the Robert Graham Center for Policy Studies in Primary Care, in Washington, DC "The significant preponderance of primary care practitioners appear to be using digital medical records in some variety or fashion".
The promises of electronic record-keeping include improved medical heed and long-term savings. However, many doctors were slow to adopt these records because of the exorbitant cost and the complexity of converting paper files. There were also privacy concerns. "We are not there yet," Bazemore added. "More duty is needed, including better information from all of the states".
The Obama dispensation has offered incentives to doctors who adopt electronic health records, and penalties to those who do not. For the study, researchers mined two inhabitant data sets to see how many family doctors were using electronic trim records, how this number changed over time, and how it compared to use by specialists. Their findings appear in the January-February subject of the Annals of Family Medicine.
Nationally, 68 percent of family doctors were using electronic constitution records in 2011, they found. Rates varied by state, with a low of about 47 percent in North Dakota and a violent of nearly 95 percent in Utah. Dr Michael Oppenheim, blemish president and chief medical information officer for North Shore Long Island Jewish Health System in Great Neck, NY, said electronic record-keeping streamlines medical care.
More than two-thirds of kids doctors now use electronic fitness records, and the percentage doing so doubled between 2005 and 2011, a unusual study finds. If the trend continues, 80 percent of family doctors - the largest bunch of primary care physicians - will be using electronic records by 2013, the researchers predicted. The findings produce "some encouragement that we have passed a critical threshold," said scan author Dr Andrew Bazemore, director of the Robert Graham Center for Policy Studies in Primary Care, in Washington, DC "The significant preponderance of primary care practitioners appear to be using digital medical records in some variety or fashion".
The promises of electronic record-keeping include improved medical heed and long-term savings. However, many doctors were slow to adopt these records because of the exorbitant cost and the complexity of converting paper files. There were also privacy concerns. "We are not there yet," Bazemore added. "More duty is needed, including better information from all of the states".
The Obama dispensation has offered incentives to doctors who adopt electronic health records, and penalties to those who do not. For the study, researchers mined two inhabitant data sets to see how many family doctors were using electronic trim records, how this number changed over time, and how it compared to use by specialists. Their findings appear in the January-February subject of the Annals of Family Medicine.
Nationally, 68 percent of family doctors were using electronic constitution records in 2011, they found. Rates varied by state, with a low of about 47 percent in North Dakota and a violent of nearly 95 percent in Utah. Dr Michael Oppenheim, blemish president and chief medical information officer for North Shore Long Island Jewish Health System in Great Neck, NY, said electronic record-keeping streamlines medical care.
Diabetes In Young Women Increases The Risk Of Cardiovascular Disease
Diabetes In Young Women Increases The Risk Of Cardiovascular Disease.
New into or finds that girls and juvenile women with type 1 diabetes show signs of jeopardy factors for cardiovascular disease at an early age. The findings don't definitively confirm that type 1 diabetes, the kind that often begins in childhood, directly causes the gamble factors, and heart attack and stroke remain rare in young people. But they do upon the differences between the genders when it comes to the risk of heart problems for diabetics, said study co-author Dr R Paul Wadwa, an subsidiary professor of pediatrics at the University of Colorado School of Medicine in Denver.
And "We're since measurable differences early in life, earlier than we expected," he said. "We insufficiency to make sure we're screening appropriately for cardiovascular peril factors, and with girls, it seems like it's even more important". According to Wadwa, diabetic adults are at higher jeopardize of cardiovascular disease than others without diabetes.
Diabetic women, in particular, seem to lose some of the safeguarding effects that their gender provides against heart problems, Wadwa said. "Women are protected from cardiovascular bug in the pre-menopausal state probably because they are exposed to sex hormones, mainly estrogen," said Dr Joel Zonszein, a clinical cure-all professor at Albert Einstein College of Medicine in New York City. "This sanctuary may be ameliorated or lost in individuals with diabetes".
It's not clear, however, when diabetic females begin to use their advantage. In the new study, Wadwa and colleagues looked specifically at order 1 diabetes, also known as juvenile diabetes since it's often diagnosed in childhood. The researchers tested 402 children and progeny adults aged 12 to 19 from the Denver area.
New into or finds that girls and juvenile women with type 1 diabetes show signs of jeopardy factors for cardiovascular disease at an early age. The findings don't definitively confirm that type 1 diabetes, the kind that often begins in childhood, directly causes the gamble factors, and heart attack and stroke remain rare in young people. But they do upon the differences between the genders when it comes to the risk of heart problems for diabetics, said study co-author Dr R Paul Wadwa, an subsidiary professor of pediatrics at the University of Colorado School of Medicine in Denver.
And "We're since measurable differences early in life, earlier than we expected," he said. "We insufficiency to make sure we're screening appropriately for cardiovascular peril factors, and with girls, it seems like it's even more important". According to Wadwa, diabetic adults are at higher jeopardize of cardiovascular disease than others without diabetes.
Diabetic women, in particular, seem to lose some of the safeguarding effects that their gender provides against heart problems, Wadwa said. "Women are protected from cardiovascular bug in the pre-menopausal state probably because they are exposed to sex hormones, mainly estrogen," said Dr Joel Zonszein, a clinical cure-all professor at Albert Einstein College of Medicine in New York City. "This sanctuary may be ameliorated or lost in individuals with diabetes".
It's not clear, however, when diabetic females begin to use their advantage. In the new study, Wadwa and colleagues looked specifically at order 1 diabetes, also known as juvenile diabetes since it's often diagnosed in childhood. The researchers tested 402 children and progeny adults aged 12 to 19 from the Denver area.
Wednesday 3 December 2014
Harm To Consumers From Changes In The Flexibility Of The Expenditure Account
Harm To Consumers From Changes In The Flexibility Of The Expenditure Account.
It's the occasion of year for vacation parties, gift shopping and open-minded enrollment, when many employees have to make decisions about their employer-sponsored health-care plans. Last year's identification health care reform legislation means changes are in store for 2011. One of the most significant: starting Jan 1, 2011, you'll no longer be able to avenge oneself for for most over-the-counter medications using a willowy spending account (FSA). That means if you're used to paying for your allergy or heartburn medication using pre-tax dollars, you're out of fluke unless your doctor writes you a prescription.
The exception is insulin, which you can still return for using an FSA even without a prescription. Flexible spending accounts, which are offered by some employers, enable employees to set aside green each month to pay for out-of-pocket medical costs such as co-pays and deductibles using pre-tax dollars. "This is basically reverting back to the direction FSAs were used a few years ago," said Paul Fronstin, a older research associate at the Employee Benefit Research Institute in Washington, DC "It wasn't that fancy ago that you couldn't use FSAs for over-the-counter medicine".
Popular uses for FSAs embody eyeglasses, dental and orthodontic work, as well as co-pays for prescription drugs, doctor visits and other procedures, explained Richard Jensen, conduct research scientist in the department of health method at George Washington University in Washington, DC Over-the-counter drugs became FSA "qualified medical expenses" in 2003, according to the Internal Revenue Service. The respect an FSA works is an staff member decides before Jan 1, 2011 (usually during the company's open enrollment period) how much funds to contribute in the year ahead. The employer deducts equal installments from each paycheck throughout the year, although the amount amount must be available at all times during the year.
Typically, FSAs operate under the "use it or lose it" rule. You have to allot all of the money placed in an FSA by the end of the calendar year or the money is forfeited, Jensen explained. Since loosely speaking, the cost of over-the-counter medications pales in balance to the cost of co-pays and deductibles, the 2011 change shouldn't be too onerous for consumers, Jensen said.
It's the occasion of year for vacation parties, gift shopping and open-minded enrollment, when many employees have to make decisions about their employer-sponsored health-care plans. Last year's identification health care reform legislation means changes are in store for 2011. One of the most significant: starting Jan 1, 2011, you'll no longer be able to avenge oneself for for most over-the-counter medications using a willowy spending account (FSA). That means if you're used to paying for your allergy or heartburn medication using pre-tax dollars, you're out of fluke unless your doctor writes you a prescription.
The exception is insulin, which you can still return for using an FSA even without a prescription. Flexible spending accounts, which are offered by some employers, enable employees to set aside green each month to pay for out-of-pocket medical costs such as co-pays and deductibles using pre-tax dollars. "This is basically reverting back to the direction FSAs were used a few years ago," said Paul Fronstin, a older research associate at the Employee Benefit Research Institute in Washington, DC "It wasn't that fancy ago that you couldn't use FSAs for over-the-counter medicine".
Popular uses for FSAs embody eyeglasses, dental and orthodontic work, as well as co-pays for prescription drugs, doctor visits and other procedures, explained Richard Jensen, conduct research scientist in the department of health method at George Washington University in Washington, DC Over-the-counter drugs became FSA "qualified medical expenses" in 2003, according to the Internal Revenue Service. The respect an FSA works is an staff member decides before Jan 1, 2011 (usually during the company's open enrollment period) how much funds to contribute in the year ahead. The employer deducts equal installments from each paycheck throughout the year, although the amount amount must be available at all times during the year.
Typically, FSAs operate under the "use it or lose it" rule. You have to allot all of the money placed in an FSA by the end of the calendar year or the money is forfeited, Jensen explained. Since loosely speaking, the cost of over-the-counter medications pales in balance to the cost of co-pays and deductibles, the 2011 change shouldn't be too onerous for consumers, Jensen said.
Wednesday 19 November 2014
How Useful Is Switching To Daylight Saving Time
How Useful Is Switching To Daylight Saving Time.
Not turning the clocks back an hour in the yield would sell a simple way to improve people's vigorousness and well-being, according to an English expert. Keeping the time the same would increase the number of "accessible" daylight hours during the capture and winter and encourage more outdoor physical activity, according to Mayer Hillman, a senior c swain emeritus at the Policy Studies Institute in London. He estimated that eliminating the time metamorphose would provide "about 300 additional hours of daylight for adults each year and 200 more for children".
Previous experiment with has shown that people feel happier, more energetic and have lower rates of illness in the longer and brighter days of summer, while people's moods look after to decline during the shorter, duller days of winter, Hillman explained in his report, published online Oct 29, 2010 in BMJ. This bid "is an effective, reasonable and remarkably easily managed way of achieving a better alignment of our waking hours with the at one's disposal daylight during the year," he pointed out in a news release from the journal's publisher.
Another expert, Dr Robert E Graham, an internist at Lenox Hill Hospital in New York City, said that he utterly agrees with Hillman's conclusions. "Lessons literate by the crack of research on the benefits of vitamin D add to the argument for 'not putting the clocks back.' Basic biochemistry has proved to us that sunlight helps your body transfigure a form of cholesterol that is present in your integument into vitamin D Additionally, several epidemiological studies have documented the seasonality of depression and other mood disorders," Graham stated.
Not turning the clocks back an hour in the yield would sell a simple way to improve people's vigorousness and well-being, according to an English expert. Keeping the time the same would increase the number of "accessible" daylight hours during the capture and winter and encourage more outdoor physical activity, according to Mayer Hillman, a senior c swain emeritus at the Policy Studies Institute in London. He estimated that eliminating the time metamorphose would provide "about 300 additional hours of daylight for adults each year and 200 more for children".
Previous experiment with has shown that people feel happier, more energetic and have lower rates of illness in the longer and brighter days of summer, while people's moods look after to decline during the shorter, duller days of winter, Hillman explained in his report, published online Oct 29, 2010 in BMJ. This bid "is an effective, reasonable and remarkably easily managed way of achieving a better alignment of our waking hours with the at one's disposal daylight during the year," he pointed out in a news release from the journal's publisher.
Another expert, Dr Robert E Graham, an internist at Lenox Hill Hospital in New York City, said that he utterly agrees with Hillman's conclusions. "Lessons literate by the crack of research on the benefits of vitamin D add to the argument for 'not putting the clocks back.' Basic biochemistry has proved to us that sunlight helps your body transfigure a form of cholesterol that is present in your integument into vitamin D Additionally, several epidemiological studies have documented the seasonality of depression and other mood disorders," Graham stated.
Monday 17 November 2014
Ecstasy In The Service Of Medicine
Ecstasy In The Service Of Medicine.
The recreational knock out known as excitement may have a medicinal role to play in helping people who have trouble connecting to others socially, uncharted research suggests. In a study involving a small group of nutritious people, investigators found that the drug - also known as MDMA - prompted heightened feelings of friendliness, playfulness and love, and induced a lowering of the security that might have therapeutic uses for improving collective interactions. Yet the closeness it sparks might not be result in deep and lasting connections.
The findings "suggest that MDMA enhances sociability, but does not inexorably increase empathy," noted study author Gillinder Bedi, an helpmeet professor of clinical psychology at Columbia University and a research scientist at the New York State Psychiatric Institute in New York City. The study, funded by the US National Institute on Drug Abuse and conducted at the Human Behavioral Pharmacology Laboratory at the University of Chicago, was published in the Dec 15 2010 edition of Biological Psychiatry.
In July, another mug up reported that MDMA might be fruitful in treating post-traumatic distress disorder (PTSD), based on the drug's seeming boosting of the ability to cope with grief by helping to control fears without numbing the crowd emotionally. MDMA is part of a family of so-called "club drugs," which are popular with some teens and puerile at all night dances or "raves".
These drugs, which are often used in combination with alcohol, have potentially life-threatening effects, according to the US National Institute on Drug Abuse. The newest muse about explored the paraphernalia of MDMA on 21 healthy volunteers, nine women and 12 men ancient 18 to 38. All said they had taken MDMA for recreational purposes at least twice in their lives.
They were randomly assigned to take i a accommodate either a low or moderate dose of MDMA, methamphetamine or a sugar pellet during four sessions in about a three-week period. Each session lasted at least 4,5 hours, or until all junk of the drug had worn off. During that time, participants stayed in a laboratory testing room, and popular interaction was limited to contact with a research assistant who helped direct cognitive exams.
The recreational knock out known as excitement may have a medicinal role to play in helping people who have trouble connecting to others socially, uncharted research suggests. In a study involving a small group of nutritious people, investigators found that the drug - also known as MDMA - prompted heightened feelings of friendliness, playfulness and love, and induced a lowering of the security that might have therapeutic uses for improving collective interactions. Yet the closeness it sparks might not be result in deep and lasting connections.
The findings "suggest that MDMA enhances sociability, but does not inexorably increase empathy," noted study author Gillinder Bedi, an helpmeet professor of clinical psychology at Columbia University and a research scientist at the New York State Psychiatric Institute in New York City. The study, funded by the US National Institute on Drug Abuse and conducted at the Human Behavioral Pharmacology Laboratory at the University of Chicago, was published in the Dec 15 2010 edition of Biological Psychiatry.
In July, another mug up reported that MDMA might be fruitful in treating post-traumatic distress disorder (PTSD), based on the drug's seeming boosting of the ability to cope with grief by helping to control fears without numbing the crowd emotionally. MDMA is part of a family of so-called "club drugs," which are popular with some teens and puerile at all night dances or "raves".
These drugs, which are often used in combination with alcohol, have potentially life-threatening effects, according to the US National Institute on Drug Abuse. The newest muse about explored the paraphernalia of MDMA on 21 healthy volunteers, nine women and 12 men ancient 18 to 38. All said they had taken MDMA for recreational purposes at least twice in their lives.
They were randomly assigned to take i a accommodate either a low or moderate dose of MDMA, methamphetamine or a sugar pellet during four sessions in about a three-week period. Each session lasted at least 4,5 hours, or until all junk of the drug had worn off. During that time, participants stayed in a laboratory testing room, and popular interaction was limited to contact with a research assistant who helped direct cognitive exams.
Friday 14 November 2014
Breakfast Cereals For Children Are A Lot Of Sugar
Breakfast Cereals For Children Are A Lot Of Sugar.
Getting kids to delightedly take nutritious, low-sugar breakfast cereals may be child's play, researchers report. A restored study finds that children will gladly chow down on low-sugar cereals if they're given a choice of choices at breakfast, and many compensate for any missing sweetness by opting for fruit instead. The 5-to-12-year-olds in the reading still ate about the same amount of calories regardless of whether they were allowed to settle upon from cereals high in sugar or a low-sugar selection.
However, the kids weren't inherently opposed to healthier cereals, the researchers found. "Don't be appalled that your child is going to refuse to eat breakfast. The kids will put it," said study co-author Marlene B Schwartz, surrogate director of Yale University's Rudd Center for Food Policy and Obesity.
Nutritionists have prolonged frowned on sugary breakfast cereals that are heavily marketed by cereal makers and gobbled up by kids. In 2008, Consumer Reports analyzed cereals marketed to kids and found that each serving of 11 primary brands had about as much sugar as a glazed donut. The journal also reported that two cereals were more than half sugar by impact and nine others were at least 40 percent sugar.
This week, aliment giant General Mills announced that it is reducing the sugar levels in its cereals geared toward children, although they'll still have much more sugar than many mature cereals. In the meantime, many parents believe that if cereals aren't insidious with sweetness, kids won't eat them.
But is that true? In the untrodden study, researchers offered different breakfast cereal choices to 91 urban children who took put in a summer day camp program in New England. Most were from minorities families and about 60 percent were Spanish-speaking.
Getting kids to delightedly take nutritious, low-sugar breakfast cereals may be child's play, researchers report. A restored study finds that children will gladly chow down on low-sugar cereals if they're given a choice of choices at breakfast, and many compensate for any missing sweetness by opting for fruit instead. The 5-to-12-year-olds in the reading still ate about the same amount of calories regardless of whether they were allowed to settle upon from cereals high in sugar or a low-sugar selection.
However, the kids weren't inherently opposed to healthier cereals, the researchers found. "Don't be appalled that your child is going to refuse to eat breakfast. The kids will put it," said study co-author Marlene B Schwartz, surrogate director of Yale University's Rudd Center for Food Policy and Obesity.
Nutritionists have prolonged frowned on sugary breakfast cereals that are heavily marketed by cereal makers and gobbled up by kids. In 2008, Consumer Reports analyzed cereals marketed to kids and found that each serving of 11 primary brands had about as much sugar as a glazed donut. The journal also reported that two cereals were more than half sugar by impact and nine others were at least 40 percent sugar.
This week, aliment giant General Mills announced that it is reducing the sugar levels in its cereals geared toward children, although they'll still have much more sugar than many mature cereals. In the meantime, many parents believe that if cereals aren't insidious with sweetness, kids won't eat them.
But is that true? In the untrodden study, researchers offered different breakfast cereal choices to 91 urban children who took put in a summer day camp program in New England. Most were from minorities families and about 60 percent were Spanish-speaking.
Thursday 13 November 2014
Healing Diabetes In Animals, We Help Heal People
Healing Diabetes In Animals, We Help Heal People.
Daniela Trnka had been living with quintessence 1 diabetes for almost 20 years when she noticed telltale signs of the c murrain in her Siberian Husky, Cooper. He was thirsty, urinating often and at times, lethargic. So she took out her blood sugar examine kit, opened a recent lancet and took a ditch of his blood. Cooper's blood glucose levels were too high. A veterinarian confirmed it: Cooper had diabetes.
Now, the two are coping with the persuade together. Trnka monitors Cooper's blood sugar levels and gives him insulin injections. Caring for her pet, Trnka says, has helped her remittance better concentration to her own health. "Every time I think to check his sugar, I'm checking mine," Trnka said. "I muse I'm more on top of managing my diabetes since I started taking feel interest of him".
Trnka recently participated in a new Canadian study focused on pets with diabetes, which found that caring for a gruesome pet may improve the pet owner's health as well. Lead investigation author Melanie Rock, an investigator at the Population Health Intervention Research Center, and a fellow-worker interviewed 16 pet owners as well as veterinarians, a mental health counselor and a formal apothecary about what it takes to take care of dogs and cats with the disease. About 1 in 500 dogs and 1 in 250 cats in developed nations are treated for diabetes, according to CV dirt in the study in the May 17 issue of Anthrozoos.
Some participants said they had learned so much about the condition they felt better equipped to embezzle care of a person with diabetes should they need to. Others, like Trnka, became more tireless about exercising daily for their pets' sake. "On a cold, windy day, my dog gets me pretence in the fresh air because I know the exercise is good for him. And that's fair for me too," she told the researchers.
So "What we observed was that people take the attention of their pet very seriously, and in doing so, they blur the lines between their own health and their pets' health," said Rock. "Being honest for a dog may get people up and out of the house on a rainy day". In addition, many indulged owners get a crash course in diabetes, a disease linked to obesity, heart disease, kidney problems and a assembly of other ills.
Daniela Trnka had been living with quintessence 1 diabetes for almost 20 years when she noticed telltale signs of the c murrain in her Siberian Husky, Cooper. He was thirsty, urinating often and at times, lethargic. So she took out her blood sugar examine kit, opened a recent lancet and took a ditch of his blood. Cooper's blood glucose levels were too high. A veterinarian confirmed it: Cooper had diabetes.
Now, the two are coping with the persuade together. Trnka monitors Cooper's blood sugar levels and gives him insulin injections. Caring for her pet, Trnka says, has helped her remittance better concentration to her own health. "Every time I think to check his sugar, I'm checking mine," Trnka said. "I muse I'm more on top of managing my diabetes since I started taking feel interest of him".
Trnka recently participated in a new Canadian study focused on pets with diabetes, which found that caring for a gruesome pet may improve the pet owner's health as well. Lead investigation author Melanie Rock, an investigator at the Population Health Intervention Research Center, and a fellow-worker interviewed 16 pet owners as well as veterinarians, a mental health counselor and a formal apothecary about what it takes to take care of dogs and cats with the disease. About 1 in 500 dogs and 1 in 250 cats in developed nations are treated for diabetes, according to CV dirt in the study in the May 17 issue of Anthrozoos.
Some participants said they had learned so much about the condition they felt better equipped to embezzle care of a person with diabetes should they need to. Others, like Trnka, became more tireless about exercising daily for their pets' sake. "On a cold, windy day, my dog gets me pretence in the fresh air because I know the exercise is good for him. And that's fair for me too," she told the researchers.
So "What we observed was that people take the attention of their pet very seriously, and in doing so, they blur the lines between their own health and their pets' health," said Rock. "Being honest for a dog may get people up and out of the house on a rainy day". In addition, many indulged owners get a crash course in diabetes, a disease linked to obesity, heart disease, kidney problems and a assembly of other ills.
Tuesday 11 November 2014
Medical Errors Are A Huge Public Health Problem
Medical Errors Are A Huge Public Health Problem.
Hospital care-related problems furnish to the deaths of about 15000 Medicare patients each month, according to a renewed federal regulation study. One in seven patients suffers harm from hospital care, including infections, bed sores and unconscionable bleeding from blood-thinning drugs, said researchers who analyzed material on 780 Medicare patients discharged from hospitals in October 2008, USA Today reported. That shop out to about 134000 of the estimated one million Medicare patients discharged that month, said the Office of Inspector General, Department of Health and Human Services.
Temporary abuse occurred in another one in seven patients whose care-related problems were detected in measure and corrected. "Reducing the incidence of adverse events in hospitals is a important component of efforts to improve patient safety and quality care," the inspector popular wrote.
Hospital care-related problems furnish to the deaths of about 15000 Medicare patients each month, according to a renewed federal regulation study. One in seven patients suffers harm from hospital care, including infections, bed sores and unconscionable bleeding from blood-thinning drugs, said researchers who analyzed material on 780 Medicare patients discharged from hospitals in October 2008, USA Today reported. That shop out to about 134000 of the estimated one million Medicare patients discharged that month, said the Office of Inspector General, Department of Health and Human Services.
Temporary abuse occurred in another one in seven patients whose care-related problems were detected in measure and corrected. "Reducing the incidence of adverse events in hospitals is a important component of efforts to improve patient safety and quality care," the inspector popular wrote.
Thursday 30 October 2014
New Promise Against Certain Types Of Lung Cancer
New Promise Against Certain Types Of Lung Cancer.
An tentative cancer deaden is proving effective in treating the lung cancers of some patients whose tumors lead a certain genetic mutation, new studies show. Because the mutation can be confer in other forms of cancer - including a rare form of sarcoma (cancer of the soft tissue), youth neuroblastoma (brain tumor), as well as some lymphomas, breast and colon cancers - researchers put they are hopeful the drug, crizotinib, will prove effective in treating those cancers as well. In one study, researchers identified 82 patients from amidst 1500 patients with non-small-cell lung cancer, the most bourgeois type of lung malignancy, whose tumors had a mutation in the anaplastic lymphoma kinase (ALK) gene.
Crizotinib targets the ALK "driver kinase," or protein, blocking its vigour and preventing the tumor from growing, explained investigate co-author Dr Geoffrey Shapiro, director of the Early Drug Development Center and associated professor of medicine at Dana-Farber Cancer Institute and Harvard Medical School, Boston. "The cancer chamber is actually addicted to the activity of the protein for its spread and survival," Shapiro said. "It's totally dependent on it. The position is that blocking that protein can kill the cancer cell".
In 46 patients taking crizotinib, the tumor shrunk by more than 30 percent during an undistinguished of six months of taking the drug. In 27 patients, crizotinib halted extension of the tumor, while in one patient the tumor disappeared.
The drug also had few side effects, Shapiro said. The most prosaic was mild gastrointestinal symptoms. "These are very positive results in lung cancer patients who had received other treatments that didn't calling or worked only briefly," Shapiro said. "The bottom underline is that there was a 72 percent chance the tumor would shrink or remain stable for at least six months".
The reading is published in the Oct 28, 2010 issue of the New England Journal of Medicine. In new years, researchers have started to think of lung cancer less as a singular disease and more as a group of diseases that rely on specific genetic mutations called "driver kinases," or proteins that okay the tumor cells to proliferate.
That has led some researchers to focus on developing drugs that butt those specific abnormalities. "Being able to inhibit those kinases and disrupt their signaling is evolving into a very thriving approach," Shapiro said.
An tentative cancer deaden is proving effective in treating the lung cancers of some patients whose tumors lead a certain genetic mutation, new studies show. Because the mutation can be confer in other forms of cancer - including a rare form of sarcoma (cancer of the soft tissue), youth neuroblastoma (brain tumor), as well as some lymphomas, breast and colon cancers - researchers put they are hopeful the drug, crizotinib, will prove effective in treating those cancers as well. In one study, researchers identified 82 patients from amidst 1500 patients with non-small-cell lung cancer, the most bourgeois type of lung malignancy, whose tumors had a mutation in the anaplastic lymphoma kinase (ALK) gene.
Crizotinib targets the ALK "driver kinase," or protein, blocking its vigour and preventing the tumor from growing, explained investigate co-author Dr Geoffrey Shapiro, director of the Early Drug Development Center and associated professor of medicine at Dana-Farber Cancer Institute and Harvard Medical School, Boston. "The cancer chamber is actually addicted to the activity of the protein for its spread and survival," Shapiro said. "It's totally dependent on it. The position is that blocking that protein can kill the cancer cell".
In 46 patients taking crizotinib, the tumor shrunk by more than 30 percent during an undistinguished of six months of taking the drug. In 27 patients, crizotinib halted extension of the tumor, while in one patient the tumor disappeared.
The drug also had few side effects, Shapiro said. The most prosaic was mild gastrointestinal symptoms. "These are very positive results in lung cancer patients who had received other treatments that didn't calling or worked only briefly," Shapiro said. "The bottom underline is that there was a 72 percent chance the tumor would shrink or remain stable for at least six months".
The reading is published in the Oct 28, 2010 issue of the New England Journal of Medicine. In new years, researchers have started to think of lung cancer less as a singular disease and more as a group of diseases that rely on specific genetic mutations called "driver kinases," or proteins that okay the tumor cells to proliferate.
That has led some researchers to focus on developing drugs that butt those specific abnormalities. "Being able to inhibit those kinases and disrupt their signaling is evolving into a very thriving approach," Shapiro said.
Tuesday 21 October 2014
Uncontrolled Intake Of Vitamin E Is An Increased Risk Of Hemorrhagic Stroke
Uncontrolled Intake Of Vitamin E Is An Increased Risk Of Hemorrhagic Stroke.
People who gobble up vitamin E supplements may be putting themselves at a disparage increased peril for a hemorrhagic stroke, researchers report. Some studies have suggested that taking vitamin E can safeguard against heart disease, while others have found that, in high doses, it might increase the chance of death. In the United States, an estimated 13 percent of the population takes vitamin E supplements, the researchers said.
And "Vitamin E supplementation is not as sheltered as we may like to believe," said result in researcher Dr Markus Schurks, who's with the division of preventive panacea at Brigham and Women's Hospital in Boston. "Specifically, it appears to carry an increased risk for hemorrhagic stroke. While the imperil is low translating into one additional hemorrhage per 1250 persons taking vitamin E, widespread and unchecked use of vitamin E should be cautioned against," he added.
The announce is published in the Nov 5, 2010 online edition of the BMJ. For the study, Schurks and his colleagues did a meta-analysis, which is a criticize of published studies, that looked at vitamin E and the risk for stroke. There are basically two types of stroke: one where blood abundance to the brain is blocked, called an ischemic stroke, and one where vessels splitting and bleed into the brain, called a hemorrhagic stroke. Of the two, hemorrhagic strokes are more rare, but more serious, the researchers noted.
The investigate team looked at nine trials that included 118756 patients. Although none of the trials found an overall danger for stroke associated with vitamin E, there was a idiosyncrasy in the risk of the type of stroke.
People who gobble up vitamin E supplements may be putting themselves at a disparage increased peril for a hemorrhagic stroke, researchers report. Some studies have suggested that taking vitamin E can safeguard against heart disease, while others have found that, in high doses, it might increase the chance of death. In the United States, an estimated 13 percent of the population takes vitamin E supplements, the researchers said.
And "Vitamin E supplementation is not as sheltered as we may like to believe," said result in researcher Dr Markus Schurks, who's with the division of preventive panacea at Brigham and Women's Hospital in Boston. "Specifically, it appears to carry an increased risk for hemorrhagic stroke. While the imperil is low translating into one additional hemorrhage per 1250 persons taking vitamin E, widespread and unchecked use of vitamin E should be cautioned against," he added.
The announce is published in the Nov 5, 2010 online edition of the BMJ. For the study, Schurks and his colleagues did a meta-analysis, which is a criticize of published studies, that looked at vitamin E and the risk for stroke. There are basically two types of stroke: one where blood abundance to the brain is blocked, called an ischemic stroke, and one where vessels splitting and bleed into the brain, called a hemorrhagic stroke. Of the two, hemorrhagic strokes are more rare, but more serious, the researchers noted.
The investigate team looked at nine trials that included 118756 patients. Although none of the trials found an overall danger for stroke associated with vitamin E, there was a idiosyncrasy in the risk of the type of stroke.
Saturday 18 October 2014
Infection Of The Heart Valve Can Cause Death.
Life-threatening infections of the insensitivity valve are twice as tired in the United States as previously thought and have increased steadily in the concluding 15 years, according to researchers. The new study also found that many cases of these infections - called endocarditis - are acquired in well-being care facilities and may be preventable. Without antibiotic treatment, these infections are fatal. Even with the best treatment, one in five patients with a nature valve infection suffers a focus attack or stroke and one in seven dies, according to study lead father Dr David Bor, chief of medicine and of infectious diseases at Cambridge Health Alliance in Massachusetts and an mate professor of medicine at Harvard Medical School.
He and a colleague analyzed popular data and recorded 39000 hospitalizations for heart valve infections in 2009. Cases have increased 2,4 percent a year since 1998, they found. The findings were published online March 20 in the chronicle PLoS One. Endocarditis is considered comparatively uncommon, study co-author Dr John Brusch said in a Cambridge Health Alliance item release.
Life-threatening infections of the insensitivity valve are twice as tired in the United States as previously thought and have increased steadily in the concluding 15 years, according to researchers. The new study also found that many cases of these infections - called endocarditis - are acquired in well-being care facilities and may be preventable. Without antibiotic treatment, these infections are fatal. Even with the best treatment, one in five patients with a nature valve infection suffers a focus attack or stroke and one in seven dies, according to study lead father Dr David Bor, chief of medicine and of infectious diseases at Cambridge Health Alliance in Massachusetts and an mate professor of medicine at Harvard Medical School.
He and a colleague analyzed popular data and recorded 39000 hospitalizations for heart valve infections in 2009. Cases have increased 2,4 percent a year since 1998, they found. The findings were published online March 20 in the chronicle PLoS One. Endocarditis is considered comparatively uncommon, study co-author Dr John Brusch said in a Cambridge Health Alliance item release.
Subscribe to:
Posts (Atom)